The Management of Advanced Heart Failure
Submission Deadline: 30 Sep 2022
Guest Editor
Mohammad Reza Movahed MD, PhD, FSCAI, FACC
College of Medicine Phoenix, University of Arizona, Phoenix, AZ, USA,College of Medicine, Tucson, University of Arizona Sarver Heart Center, Tucson, AZ, USA
Interests: cardiovascular disease; coronary intervention; non-invasive cardiology; heart failure; and cardiovascular epidemiology
Special Issue Information
Dear Colleagues,
With an aging population and the increasing prevalence of myocardial infarction and coronary artery disease, the long-term effect of the myocardial damage can lead to worsening heart failure. Furthermore, the incidence of non-ischemic cardiomyopathy and amyloidosis will raise. The patients with advanced heart failure have very high utilization with high recurrent hospitalization and device utilization. Optimal treatment and management of these patients are very important for better outcomes and cost-saving. With this issue, hopefully, we can address some difficulties in the management of this population.
- Stage D Heart failure. What are the options?
- Optimal Treatment of Systolic Heart failure
- Optimal Treatment of diastolic Heart Failure
- When Cardiac Support Device Implantation is Indicated?
- Indication for Cardiac transplantation and contraindications
- Destination Therapy
Prof. Mohammad Reza Movahed
Guest Editor
Keywords
- congestive heart failure
- systolic heart failure
- diastolic heart failure
- endstage heart failure
- cardiogenic shock
- cardiac support devices
- cardiac transplantation
Published Paper (1)
Efficacy of Non-Invasive Ventilation in Acute Coronary Syndrome Patients with Acute Systolic Heart Failure
Rev. Cardiovasc. Med. 2022, 23(9), 294; https://doi.org/10.31083/j.rcm2309294
(This article belongs to the Special Issue The Management of Advanced Heart Failure)